Cooper Companies (NASDAQ:COO) Stock Breaks Below 50-Day Moving Average – Here’s What Happened

The Cooper Companies, Inc. (NASDAQ:COO) passed below its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $60.33 and traded as low as $59.01. Cooper Companies shares last traded at $59.55, with a volume of 7,892,171 shares.

Key Cooper Companies News

Here are the key news stories impacting Cooper Companies this week:

• Neutral Sentiment: Cooper Companies is expected to report fourth-quarter results soon. Analysts reportedly anticipate a single-digit decline in earnings per share, making the upcoming release important for confirming whether recent operational issues are temporary or more persistent. Cooper Companies quarterly earnings preview
• Negative Sentiment: CEO Albert White has stepped down following pressure from activist investor Elliott Investment Management. The leadership transition adds uncertainty as Cooper works to address investor concerns about performance and strategy. Cooper Companies CEO steps down
• Negative Sentiment: Investors continue to focus on the company’s disclosure that U.S. channel inventory was being reduced. The issue was cited as a major factor behind the sharp selloff following third-quarter results and raised concerns about near-term demand, sales timing and execution. Cooper Companies scrutinized over inventory reductions
• Negative Sentiment: Several law firms, including Rosen Law Firm and Glancy Prongay Wolke & Rotter, are investigating potential securities claims related to allegations that Cooper Companies provided materially misleading business information. These announcements do not establish wrongdoing, but they increase reputational, legal and investor-sentiment risks. Cooper Companies securities investigation
• Negative Sentiment: The combination of channel destocking, a CEO departure, projected earnings pressure and multiple securities-law investigations is weighing on confidence in COO, despite the company’s prior quarterly EPS beat and full-year 2026 guidance.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. William Blair downgraded Cooper Companies from an “outperform” rating to a “market perform” rating in a report on Thursday, September 10th. Citigroup restated a “neutral” rating and set a $60.00 price objective (down from $80.00) on shares of Cooper Companies in a research report on Thursday, September 10th. Zacks Research cut shares of Cooper Companies from a “hold” rating to a “strong sell” rating in a research note on Friday, September 11th. Piper Sandler reaffirmed a “neutral” rating on shares of Cooper Companies in a report on Thursday, October 15th. Finally, Barclays upgraded shares of Cooper Companies to a “hold” rating in a research note on Wednesday, October 7th. Four equities research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, Cooper Companies currently has an average rating of “Hold” and a consensus price target of $68.60.

Cooper Companies Stock Performance

The firm has a fifty day moving average of $60.33 and a 200-day moving average of $69.09. The company has a quick ratio of 0.73, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. The stock has a market capitalization of $11.32 billion, a price-to-earnings ratio of 20.32, a PEG ratio of 2.45 and a beta of 0.83.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.12 by $0.03. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.10 billion. During the same period last year, the firm posted $0.49 EPS. The firm’s revenue for the quarter was up .5% on a year-over-year basis. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.53 EPS for the current year.

Cooper Companies declared that its Board of Directors has authorized a stock repurchase plan on Wednesday, September 9th that permits the company to repurchase $3 billion in outstanding shares. This repurchase authorization permits the medical device company to purchase up to 22.7% of its stock through open market purchases. Share repurchase plans are often an indication that the company’s leadership believes its shares are undervalued.

Insider Transactions at Cooper Companies

In other Cooper Companies news, Director Walter M. Rosebrough, Jr. purchased 3,000 shares of the stock in a transaction on Monday, September 14th. The stock was bought at an average price of $54.29 per share, for a total transaction of $162,870.00. Following the acquisition, the director directly owned 20,000 shares of the company’s stock, valued at $1,085,800. This represents a 17.65% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, Director Lawrence Kurzius bought 10,000 shares of the stock in a transaction that occurred on Wednesday, September 16th. The stock was bought at an average price of $54.93 per share, with a total value of $549,300.00. Following the completion of the acquisition, the director owned 31,099 shares of the company’s stock, valued at $1,708,268.07. This trade represents a 47.40% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought a total of 34,701 shares of company stock worth $1,880,039 over the last ninety days. 2.08% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of COO. BlackRock Inc. purchased a new position in Cooper Companies in the second quarter valued at about $1,077,762,000. Generation Investment Management LLP purchased a new stake in Cooper Companies during the 2nd quarter worth $356,304,000. Jupiter Topco LLC purchased a new stake in Cooper Companies during the 2nd quarter worth $305,074,000. Bank of America Corp DE acquired a new position in Cooper Companies in the 2nd quarter worth $144,125,000. Finally, Manning & Napier Advisors LLC acquired a new position in Cooper Companies in the 2nd quarter worth $107,939,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Company Profile

CooperCompanies is a global medical device company that develops, manufactures and markets products for vision care and women’s health. The company operates through two primary business segments: CooperVision and CooperSurgical.

CooperVision provides contact lenses and related technologies, including products designed for myopia management, astigmatism, presbyopia and other vision-correction needs. Its portfolio includes daily disposable, reusable and specialty contact lenses sold through eye-care professionals and distributors.

CooperSurgical develops products and services for fertility and women’s health.